NasdaqGM - Delayed Quote USD
Eton Pharmaceuticals, Inc. (ETON)
At close: October 21 at 4:00 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
31,740.00
25,030.00
27,465.00
26,319.00
--
Total Liabilities Net Minority Interest
16,263.00
11,952.00
9,835.00
10,656.00
--
Total Equity Gross Minority Interest
15,477.00
13,078.00
17,630.00
15,663.00
--
Total Capitalization
15,477.00
18,462.00
22,892.00
22,426.00
--
Common Stock Equity
15,477.00
13,078.00
17,630.00
15,663.00
--
Capital Lease Obligations
22.00
107.00
15.00
99.00
--
Net Tangible Assets
10,738.00
8,324.00
14,009.00
15,088.00
--
Working Capital
10,598.00
13,543.00
19,046.00
20,907.00
--
Invested Capital
20,857.00
19,495.00
24,310.00
22,706.00
--
Tangible Book Value
10,738.00
8,324.00
14,009.00
15,088.00
--
Total Debt
5,402.00
6,524.00
6,695.00
7,142.00
--
Share Issued
25,688.06
25,353.12
24,626.00
24,312.81
--
Ordinary Shares Number
25,688.06
25,353.12
24,626.00
24,312.81
--
12/31/2019 - 11/13/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HROW Harrow, Inc.
56.42
-1.84%
AQST Aquestive Therapeutics, Inc.
4.9500
-1.59%
DERM Journey Medical Corporation
6.32
+3.27%
IRWD Ironwood Pharmaceuticals, Inc.
4.1900
-4.77%
INDV Indivior PLC
8.27
-3.39%
ITCI Intra-Cellular Therapies, Inc.
76.91
-1.83%
ASRT Assertio Holdings, Inc.
1.1500
-0.86%
SUPN Supernus Pharmaceuticals, Inc.
33.67
-2.52%
BFRI Biofrontera Inc.
0.9427
+12.23%
TXMD TherapeuticsMD, Inc.
1.5750
-3.96%